Welcome to the 2026 Indonesia Market Entry Workshop. If you have found your way to this manual, you already understand the strategic calculus: Indonesia is the largest healthcare market in ASEAN by population—over 275 million people—and it is now governed by one of the region's most structured regulatory frameworks. The "Sleeping Giant" is awake, and it has installed a digital gatekeeper called the Regalkes portal.
Under Permenkes No. 11 of 2025—which replaces the previous regulatory framework under 62/2017—your CSDT dossier has been transformed from a administrative document into a digital key. If it is not formatted to the letter of the specification, the Regalkes portal will reject it at the upload gate. You will not receive a reviewer's feedback. You will receive a system error. This manual walks you through the exact steps required to get through that gate.
Workshop Prerequisites
Before we begin, confirm you have the following ready on your workstation:
- A complete set of technical documentation organized per the ASEAN CSDT structure—Executive Summary, Essential Principles checklist, Device Description, Design & Manufacturing Information, Pre-clinical Studies, Clinical Evidence, and Labeling
- Digital copies of all regulatory certifications from your reference market (CE marking certificate, FDA 510(k) clearance letter, or equivalent)
- Your Local Authorized Representative (LAR) contact details and a scanned copy of their current license documentation
- Access to a PDF editor capable of structured bookmarking (we recommend a professional-grade tool—do not attempt this with a browser-based freeware solution)
Let us begin. Follow each step in order. Do not skip steps. The sequence matters.
Step 1: Verify the CDAKB Prerequisite
What you need to do: Before you open a single PDF, audit your Local Authorized Representative.
Why this matters: Under Permenkes 11/2025, the Indonesian Ministry of Health (Kemenkes) has linked the Regalkes registration portal to the CDAKB (Cara Distribusi Alat Kesehatan yang Baik—Good Distribution Practice for Medical Devices) database. This is not a separate submission step. The portal checks your LAR's CDAKB certification status automatically at the point of dossier upload. If their certificate is expired, suspended, or not yet issued, the system blocks the upload entirely.
Your action: Contact your LAR and request a copy of their current CDAKB certificate. Check the expiration date—not the issue date. Verify that the certificate covers the device category you are registering. If there is any doubt, resolve it before proceeding to Step 2. A lapsed CDAKB certificate at the submission stage will cost you weeks, not days.
Step 2: Address the Halal Compliance Deadline
What you need to do: Check your device's material composition for any animal-derived content. If present, initiate the Halal certification process immediately.
Why this matters: Indonesia's Halal Product Assurance Law establishes a hard deadline of October 17, 2026 for Class A medical devices, with Phase 2—covering Class B devices—following in 2029. This is not a guideline. It is a legislative deadline. Devices containing animal-derived materials that have not completed Halal certification by their respective deadline dates will face market access restrictions. If your device contains no animal-derived components, you still need to document this determination formally in your dossier—do not assume silence on the matter will be interpreted as compliance.
Your action: List every material in your device supply chain. For any animal-derived material, contact BPJPH (Badan Penyelenggara Jaminan Produk Halal) or an accredited Halal certification body and begin the process. For devices with no animal-derived materials, prepare a signed declaration to this effect with supporting material specification sheets, and place it in your dossier's Essential Principles section. If you are reading this in mid-2026 and your device requires Halal certification, you are already on a critical timeline.
Step 3: Apply the Language Rule Correctly
What you need to do: Localize all safety-critical user-facing materials into Bahasa Indonesia. Technical reports may remain in English under specific conditions.
Why this matters: The rule is precise, and misapplication is a common rejection trigger. Labeling—including the primary label on the device itself—and Instructions for Use (IFU) must be in Bahasa Indonesia. This is mandatory for all device classes. Technical documents—Form B submissions, clinical evaluation reports, pre-clinical study summaries—are accepted in English, as long as the content is accurate and complete. However, if a technical document contains any safety-critical instruction that a healthcare professional at the point of use would need to read, that portion must be localized.
Your action: Review every page of your labeling and IFU. If you see English, replace it with Bahasa Indonesia—or provide a bilingual version with Bahasa Indonesia as the primary language. For technical reports, identify any embedded safety instructions and extract them for translation. Do not rely on machine translation alone; have a medically qualified Bahasa Indonesia speaker review the output.
Step 4: Use the Apostille Shortcut
What you need to do: Apostille your Letter of Authorization (LoA) and Free Sale Certificate (FSC) in your home country. Stop visiting the embassy.
Why this matters: Indonesia has ratified the Apostille Convention. This means foreign public documents—including notarized Letters of Authorization and government-issued Free Sale Certificates—no longer require multi-layer embassy legalization. An Apostille stamp from the competent authority in the document's country of origin is sufficient for Kemenkes recognition. This saves approximately four to six weeks of administrative processing time compared to the previous embassy legalization chain.
Your action: Identify the competent Apostille authority in your country (typically the Ministry of Foreign Affairs, State Department, or equivalent). Submit your LoA and FSC for Apostille certification. Attach the Apostilled versions—not the non-Apostilled originals—to your dossier. If your LoA and FSC originate from different countries, each must be Apostilled by its respective issuing country's authority. Do not assume one Apostille covers both documents.
Step 5: Format Each CSDT Section to Specification
What you need to do: Work through each section of your CSDT dossier and verify it against the formatting checklist below. Treat this as a quality control gate—every section must pass before the dossier is assembled for upload.
| CSDT Section | Workshop Checkpoint | Common Failure Mode |
|---|---|---|
| Executive Summary | Must include a table of "foreign market approval history" listing every ASEAN and reference-country registration, with approval dates and certificate numbers | Listing approvals without certificate numbers—Kemenkes verifies these against their own database |
| Essential Principles | Conformity checklist must reference risk management data aligned with ISO 14971:2019; each principle must cite a specific section of your technical file | Generic checkbox completion without cross-referencing the technical documentation that supports each claim |
| Clinical Evidence | Required for Class C and D devices. Literature review references must be published within the last 24 months. Include a signed clinical evaluation report | Submitting literature reviews citing studies older than 24 months without justification for their continued relevance |
| Labeling | Must show the Kemenkes AKL (SatuSehat platform) integration QR code if the device is subject to traceability requirements. Bahasa Indonesia must be the primary language on all labels | QR code omission on devices where traceability is mandatory; English-primary labeling |
Step 6: The Instructor's Pro-Tip: File Naming and Portal Upload
What you need to do: Name every file according to the Regalkes template before you open the upload interface. Then check the names again.
Why this matters: The Regalkes e-portal enforces strict file naming conventions. A single space in the wrong position, a single underscore where a hyphen is expected, or a file extension in the wrong case will trigger a system-level error. These errors are not reviewed by a human. They are automatic rejections that return you to the beginning of the upload sequence. Common examples of correct naming patterns include: DOC_BRAND_NAME.pdf, IFU_DEVICE_MODEL.pdf, FSC_COUNTRY_APOSTILLE.pdf. The template is provided on the Regalkes portal itself—download it, print it, and check each file against it physically before commencing the upload.
The portal also enforces file size limits and a single-session upload constraint. If your session times out mid-upload—and the timeout window is shorter than you expect—you will lose all progress and must restart. Prepare all files, verify all names, and only then begin the upload session.
Workshop Wrap-Up: Your Submission Checklist
Before you click "Submit," work through this final checklist:
- CDAKB certificate validated—current, correct category, not expiring within 30 days
- Halal compliance pathway documented—certification initiated or formal declaration of no animal-derived materials filed
- All labeling and IFU in Bahasa Indonesia—verified by a medically qualified native speaker
- LoA and FSC Apostilled and attached—not non-Apostilled originals
- CSDT sections formatted to specification—Executive Summary with certificate numbers, Essential Principles with ISO 14971:2019 cross-references, Clinical Evidence within 24-month window, Labeling with QR code where applicable
- File naming audited against the Regalkes template—no spaces, no wrong separators, no incorrect extensions
- All files compressed and sized within portal limits
If every item on this checklist is confirmed, your dossier is ready for submission. The Indonesian medical device market rewards preparation and punishes haste. You have done the work. Now submit with confidence.
Disclaimer: This article provides general industry information and does not constitute regulatory or legal advice. For specific compliance requirements, please consult with our procurement advisory team or relevant national authorities.
Sources: Permenkes No. 11 of 2025 – Indonesian Ministry of Health; ASEAN Medical Device Directive (AMDD) CSDT Guidelines; BPJPH Halal Product Assurance Framework; Apostille Convention Implementation Guidelines for Medical Device Documentation.